Laydon v. Mizuho Bank, Ltd. et al., No. 12-cv-03419 (S.D.N.Y.) involves allegations that numerous financial institutions conspired to manipulate the Yen London Interbank Offered Rate (“Yen-LIBOR”) and the Euroyen Tokyo Interbank Offered Rate (“TIBOR”) to financially benefit their derivatives positions. Multiple Defendants have pleaded guilty to criminal charges of price-fixing and paid billions in fines to regulators for this misconduct. Further, Defendant UBS AG was granted conditional leniency from the U.S. Department of Justice (“DOJ”) under the Antitrust Criminal Penalty Enhancement and Reform Act (“ACPERA”) for admitting to anticompetitive conduct in the Euroyen market. The case is currently pending before Judge Daniels.
Sullivan et al. v. Barclays PLC et al., No. 13-cv-2811 (S.D.N.Y.) alleges that banks responsible for setting the Euro Interbank Offered Rate (“Euribor”) conspired to fix Euribor-based derivatives prices to financially benefit their own trading positions. Defendants named in the lawsuit have paid billions in fines, including to the DOJ, European Commission (“EC”), and U.K. Financial Conduct Authority (“FCA”). They have also received conditional lenience under ACPERA and the equivalent EC programs for their admitted anticompetitive conduct in the Euribor market. The case is currently pending before Judge Castel.
In re: London Silver Fixing Ltd. Antitrust Litigation, No. 1:14-md-02573 (S.D.N.Y.) concerns the alleged manipulation of the London Silver Fixing, the global benchmark price for silver, in violation of the Sherman Antitrust Act and the Commodities Exchange Act. Traders employed by Defendants named in the lawsuit have been indicted on and pleaded guilty to Commodity Exchange Act violations for manipulating the prices of silver futures contracts traded on COMEX. Lowey Dannenberg was appointed as Co-Lead Counsel in this matter in November 2014. The case is currently pending before Judge Caproni.
Sonterra Capital Master Fund Ltd. et al. v. Credit Suisse Group AG et al., No. 15-cv-0871 (S.D.N.Y.) alleges that numerous global financial institutions conspired to fix the prices of financial derivatives priced based on the London Interbank Offered Rate for the Swiss Franc (“Swiss Franc LIBOR”). Defendants named in the lawsuit have settled with global regulators, paid billions in fines, and been granted leniency by the EC for engaging in anticompetitive conduct in the Swiss Franc LIBOR derivatives market. This includes an unlawful agreement to fix artificially wider bid-ask spreads in the over-the-counter market. Lowey Dannenberg was appointed sole interim class counsel in May 2015. The case is currently pending before Judge Stein.
Sonterra Capital Master Fund Ltd., et al. v. Barclays Bank PLC, et al., No. 15-cv-03538 (S.D.N.Y.) involves claims against numerous global financial institutions that allegedly conspired to manipulate the Sterling London Interbank Offered Rate (“Sterling LIBOR”) for their financial benefit. Defendants named in the action have already settled with multiple government regulators including the DOJ, CFTC, and FCA. The case is currently pending before Judge Broderick.
Frontpoint Asian Event Driven Fund et al. v. Citibank N.A., et al., No. 16-cv-05263 (S.D.N.Y.) encompasses claims arising out of the alleged manipulation of the Singapore Interbank Offered Rate (“SIBOR”) and Singapore Swap Offer Rate (“SOR”), two benchmarks used to measure the cost of borrowing Singapore dollars. Multiple financial regulators, including the Monetary Authority of Singapore, have already found that Defendants named in the action made false submissions to manipulate those rates for their financial benefit. The case is currently pending before Judge Hellerstein.
Dennis et al. v. JPMorgan Chase & Co. et al., No. 16-cv-6496 alleges that financial institutions responsible for setting the Australian dollar Bank Bill Swap Rate (“BBSW”) conspired to manipulate that rate to financially benefit their derivatives trading positions. Defendants in the case have entered settlements with the Australian Securities Investment and Commission admitting to the alleged misconduct. The case is currently pending before Judge Kaplan.
An avid computer programmer, Mr. Levis is a recognized expert on e-discovery and the use of technology-assisted review. In 2017, he was invited to present An Analytics Cookbook for Complex Cases at Relativity Fest, a leading industry conference. He has also hosted various webinars and written tutorials on how to layer different review techniques to increase efficiency when dealing with large datasets. Mr. Levis also uses his experience with computer science to develop custom software that can assist clients in identifying possible damage by market manipulation.
Prior to joining Lowey Dannenberg, Mr. Levis clerked for the Honorable Jessica R. Mayer in the Superior Court of New Jersey, working on mass tort cases involving the drugs and medical devices Zometa/Aredia, HRT, Alloderm, Propecia, Risperdal/Seroquel/Zyprexa, and Gadolinium. At Fordham Law School, he was an associate editor of the Fordham Intellectual Property, Media and Entertainment Law Journal. He also served as the interschool competitions director for the Brendan Moore Trial Advocacy Center, winning 2 national trial competitions in addition to an individual best advocate award. In recognition of these accomplishments, Mr. Levis received the Abraham Abramovsky Award for outstanding achievement in trial advocacy in 2012.
Mr. Levis received his undergraduate degrees in biology and English from New York University, where his statistical analysis of Tuberculosis infection rates among members of New York City’s homeless population earned him a research grant and the designation of University Honors Scholar.
He also teaches as an adjunct professor of trial advocacy at Fordham University School of Law.
B.A. New York University (2008), cum laude
J.D. Fordham University School of Law (2012)
New York, New Jersey, United States District Court for the Southern District of New York, and the United States Courts of Appeals for the Second and Ninth Circuits
More than 50 years of landmark results.